Literature DB >> 3185902

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease.

H Crystal1, D Dickson, P Fuld, D Masur, R Scott, M Mehler, J Masdeu, C Kawas, M Aronson, L Wolfson.   

Abstract

We compared neuropsychological findings in 28 longitudinally evaluated elderly subjects with their postmortem neuropathology, including senile plaque and neurofibrillary tangle counts from standardized sections. Nine of the subjects were not demented when evaluated just prior to their death. Numerous cortical senile plaques and other changes of Alzheimer's disease (AD) occurred in six of nine nondemented old-old subjects. Five of these six subjects had shown decline on yearly neuropsychological tests but their cognitive impairment was too mild to meet clinical criteria for dementia. Whereas cortical senile plaque count did not distinguish well between demented and nondemented subjects, every subject with numerous cortical neurofibrillary tangles was demented. The nondemented subjects with Alzheimer pathology may have had "preclinical" AD, or numerous cortical plaques may occur in some elderly subjects who would never develop clinical dementia.

Entities:  

Mesh:

Year:  1988        PMID: 3185902     DOI: 10.1212/wnl.38.11.1682

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  162 in total

1.  The importance of cognitive aging for understanding dementia.

Authors:  Archana Singh-Manoux; Mika Kivimäki
Journal:  Age (Dordr)       Date:  2010-05-08

2.  Alzheimer neuropathology in non-Down's syndrome mentally retarded adults.

Authors:  E R Popovitch; H M Wisniewski; M Barcikowska; W Silverman; C Bancher; E Sersen; G Y Wen
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

4.  CSF biomarkers for Alzheimer's disease: current utility and potential future use.

Authors:  David M Holtzman
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

5.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

6.  Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.

Authors:  Sabine Ott; Andreas Wolfram Henkel; Maria Kerstin Henkel; Zoran B Redzic; Johannes Kornhuber; Jens Wiltfang
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

Review 7.  Diagnosing dementia in the oldest-old.

Authors:  Carrie Brumback-Peltz; Archana B Balasubramanian; María M Corrada; Claudia H Kawas
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

8.  Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease.

Authors:  A Parachikova; C W Cotman
Journal:  Neurobiol Dis       Date:  2007-07-10       Impact factor: 5.996

Review 9.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Clinico-pathological correlation in dementias.

Authors:  F Teixeira; E Alonso; V Romero; A Ortíz; C Martínez; E Otero
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.